Healthcare provider profile · identity verified

Duane Lee Wilcox, NP

Nurse Practitioner · CLARKLAKE, MI · NPI 1356836233

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	430	52
Atorvastatin Calcium	Atorvastatin Calcium	345	71
Eliquis	Apixaban	307	44
Furosemide	Furosemide	281	66
Levothyroxine Sodium	Levothyroxine Sodium	254	49
Omeprazole	Omeprazole	235	57
Potassium Chloride	Potassium Chloride	230	58
Metoprolol Tartrate	Metoprolol Tartrate	205	60
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	204	54
Jardiance	Empagliflozin	193	36
Lantus	Insulin Glargine,hum.Rec.Anlog	193	29
Lorazepam	Lorazepam	191	48
Pantoprazole Sodium	Pantoprazole Sodium	190	47
Metformin Hcl	Metformin Hcl	182	29
Duloxetine Hcl	Duloxetine Hcl	156	31
Amlodipine Besylate	Amlodipine Besylate	153	40
Lisinopril	Lisinopril	146	34
Tamsulosin Hcl	Tamsulosin Hcl	139	33
Metoprolol Succinate	Metoprolol Succinate	131	38
Famotidine	Famotidine	122	29
Escitalopram Oxalate	Escitalopram Oxalate	117	31
Donepezil Hcl	Donepezil Hcl	113	18
Tramadol Hcl	Tramadol Hcl	111	28
Humalog	Insulin Lispro	110	19
Sertraline Hcl	Sertraline Hcl	109	19
Clopidogrel	Clopidogrel Bisulfate	105	24
Latanoprost	Latanoprost	97	19
Memantine Hcl	Memantine Hcl	92	15
Trazodone Hcl	Trazodone Hcl	88	18
Mirtazapine	Mirtazapine	87	24
Allopurinol	Allopurinol	86	13
Warfarin Sodium	Warfarin Sodium	84	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	83	12
Quetiapine Fumarate	Quetiapine Fumarate	83	12
Losartan Potassium	Losartan Potassium	78	26
Oxycodone Hcl	Oxycodone Hcl	78	23
Januvia	Sitagliptin Phosphate	77	16
Divalproex Sodium	Divalproex Sodium	76	15
Lacosamide	Lacosamide	71	suppressed
Pregabalin	Pregabalin	66	12
Metolazone	Metolazone	63	19
Bumetanide	Bumetanide	59	15
Carvedilol	Carvedilol	58	17
Fluticasone Propionate	Fluticasone Propionate	58	20
Ropinirole Hcl	Ropinirole Hcl	58	suppressed
Simvastatin	Simvastatin	58	13
Buspirone Hcl	Buspirone Hcl	54	14
Levetiracetam	Levetiracetam	54	suppressed
Pravastatin Sodium	Pravastatin Sodium	53	suppressed
Lamotrigine	Lamotrigine	52	suppressed
Morphine Sulfate	Morphine Sulfate	52	28
Hydrocortisone	Hydrocortisone	51	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	51	11
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Hydralazine Hcl	Hydralazine Hcl	50	18
Risperidone	Risperidone	41	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	41	13
Solifenacin Succinate	Solifenacin Succinate	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	39	26
Montelukast Sodium	Montelukast Sodium	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	21
Arexvy	Rsvpref3 Antigen/As01e/Pf	37	37
Ceftriaxone	Ceftriaxone Sodium	37	29
Baclofen	Baclofen	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Xarelto	Rivaroxaban	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Timolol Maleate	Timolol Maleate	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	suppressed
Midodrine Hcl	Midodrine Hcl	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Lovastatin	Lovastatin	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Methocarbamol	Methocarbamol	29	16
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Azithromycin	Azithromycin	28	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	28	suppressed
Novolog	Insulin Aspart	28	12
Torsemide	Torsemide	28	suppressed
Cephalexin	Cephalexin	27	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	20
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Levemir	Insulin Detemir	26	suppressed
Glipizide	Glipizide	25	suppressed
Lidocaine Hcl	Lidocaine Hcl	25	20
Prednisone	Prednisone	24	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	14
Farxiga	Dapagliflozin Propanediol	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	22	suppressed
Restasis	Cyclosporine	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Mounjaro	Tirzepatide	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Fentanyl	Fentanyl	17	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Colchicine	Colchicine	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Digoxin	Digoxin	16	suppressed
Insulin Aspart	Insulin Aspart	16	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	16	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Fiasp	Insulin Aspart (Niacinamide)	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Atenolol	Atenolol	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bicalutamide	Bicalutamide	13	suppressed
Finasteride	Finasteride	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Lagevrio (Eua)	Molnupiravir	13	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Combigan	Brimonidine Tartrate/Timolol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Belbuca	Buprenorphine Hcl	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fluorometholone	Fluorometholone	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error